New Light-Based brain scan could revolutionize diagnosis of rare intellectual disabilities

NCT ID NCT06868979

Recruiting now Diagnosis Sponsor: Hospices Civils de Lyon Source: ClinicalTrials.gov ↗

First seen Apr 04, 2026 · Last updated May 23, 2026 · Updated 6 times

Summary

This study aims to develop a simple, non-invasive brain imaging technique using light (fNIRS) to measure brain function in people with Fragile X Syndrome and Creatine Transporter Deficiency. Researchers will test if this method can detect unique brain activity patterns that could serve as biomarkers for diagnosis and treatment monitoring. The study involves 118 participants aged 5 to 35, including both males and females with these conditions.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for CREATINE TRANSPORTER DEFICIENCY are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Show contact details

Study contacts

Contact

Phone: •••-•••-•••• Email: •••••@•••••

Locations

Woman, mother and child hospital, Hospices Civils de Lyon
RECRUITING

Bron, 69500, France

Contact Phone: •••-•••-•••• Email: •••••@•••••

Contact

Conditions

Explore the condition pages connected to this study.

CREATINE TRANSPORTER DEFICIENCY FRAGILE X SYNDROME (FXS)